Decay Accelerating Factor and B cell Immunity
衰变加速因子和 B 细胞免疫
基本信息
- 批准号:9817322
- 负责人:
- 金额:$ 42.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-17 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAffinityAlternative Complement PathwayAntibodiesAntibody AffinityAntibody FormationAntibody ResponseAntibody titer measurementAntigensAutoimmune ProcessAutoimmunityB Cell ProliferationB-Cell ActivationB-LymphocytesBCL6 geneBiologicalBiologyC3AR1 geneC5a anaphylatoxin receptorCD55 AntigensCell SurvivalCell surfaceCellular biologyChromosomes, Human, Pair 1ComplementComplement 3 ConvertaseComplement 3aComplement 3d ReceptorsComplement 5aComplement ActivationDataDevelopmentDiseaseDown-RegulationEnhancersEventFollicular Dendritic CellsFutureGenerationsGenesGenetic TranscriptionHumoral ImmunitiesImmune responseImmunityImmunizationImmunoglobulin Somatic HypermutationImpairmentInfectionLiftingLigationLightLinkLymphoidMediatingMediator of activation proteinMemory B-LymphocyteModelingMolecularMusOutcomeOutputPathogenicityPhysiologicalPlasma CellsProcessProductionReactionReagentReceptor SignalingRegulationRepressionResearchRoleSignal PathwaySignal TransductionSolidStructureStructure of germinal center of lymph nodeSystemT-LymphocyteTestingTransgenic OrganismsTransplantationVaccineschronic graft versus host diseasecomplement C3d,gcomplement pathwaygene repressiongenetic regulatory proteinin vivoinsightmembernovelorgan transplant rejectionoverexpressionpathogenpreventprogramspromoterreceptorresponserestraint
项目摘要
Project Summary
Humoral immunity crucially protects against pathogens but can function as a pathogenic mediator of multiple
autoimmune and alloimmune disease processes, the latter including chronic graft vs. host disease and
antibody-mediated solid organ transplant rejection. Development of antigen-specific antibody responses
requires T cell-dependent B cell activation and the formation of germinal centers (GC), transient lymphoid
structures where somatic hypermutation and affinity maturation events result in the generation of high affinity,
antibody-producing plasma cells (PC) and memory B cells (Bmem). The physiological signals that control GC
formation and GC B cell fates are incompletely characterized. Our preliminary data identify a previously
unappreciated role for decay accelerating factor (DAF or CD55), a cell surface-expressed complement
regulatory protein, in controlling GC reactions and their resultant output, the production of PC and Bmem. Our
data support the hypothesis that optimal GC function requires downregulation of cell surface expressed DAF
on responding B cells, a process that lifts restraint on local, alternative pathway complement activation and
facilitates C3- and C5-convertase formation and production of C3 and C5 cleavage products. This process
promotes C3a/C3aR1 and C5a/C5aR1 ligations on GC B cells, which would in turn transduce signals
controlling GC B cell proliferation, survival, somatic hypermutation, and/or affinity maturation, and as a
consequence, influence differentiation into memory B cells and/or plasma cells. We will test this paradigm-
shifting hypothesis using unique biological reagents and through 3 interactive aims: 1) To determine the effects
of B cell-expressed DAF, C3aR1 and C5aR1 on T cell-dependent humoral immune responses and distinguish
them from the effects of B cell-expressed CD21. 2) To determine the cellular and molecular mechanisms
through which DAF downregulation and enhanced signaling through C3aR1/C5aR1 in B cells drive affinity
maturation. 3) To determine the molecular basis of DAF downregulation on B cells. This comprehensive
analysis performed by a multi-PI team with expertise in complement biology (Heeger) and B cell biology
(Dominguez-Sola) is likely to provide new insight into fundamental mechanisms of GC dynamics and function.
The results have the potential to guide second order studies aimed at exploiting the complement/B cell axis to
either inhibit development of pathogenic B cell responses (e.g. in transplantation or autoimmunity) or augment
B cell response (e.g. in response to vaccines).
项目摘要
体液免疫至关重要地保护免受病原体,但可以作为多种病原体的致病介质。
自身免疫和同种免疫疾病过程,后者包括慢性移植物抗宿主病,
抗体介导的实体器官移植排斥反应。抗原特异性抗体应答的产生
需要T细胞依赖性B细胞活化和生发中心(GC)、瞬时淋巴样
其中体细胞超突变和亲和力成熟事件导致产生高亲和力的结构,
产生抗体的浆细胞(PC)和记忆B细胞(B细胞)。控制GC的生理信号
形成和GC B细胞命运的特征不完全。我们的初步数据显示,
衰变加速因子(CD 55),一种细胞表面表达的补体,
调节蛋白,在控制GC反应和其最终输出,PC和甜菜碱的生产。我们
数据支持最佳的GC功能需要下调细胞表面表达的GC的假设。
在应答B细胞上,这是一个解除对局部替代途径补体激活的抑制的过程,
促进C3-和C5-转化酶的形成和C3和C5裂解产物的产生。这个过程
促进GC B细胞上的C3 a/C3 aR 1和C5 a/C5 aR 1连接,这反过来会抑制信号传导
控制GC B细胞增殖、存活、体细胞超突变和/或亲和力成熟,以及作为
从而影响分化成记忆B细胞和/或浆细胞。我们将测试这个范例-
使用独特的生物试剂和通过3个互动的目标来改变假设:1)确定影响
B细胞表达的C3 aR 1和C5 aR 1对T细胞依赖性体液免疫应答的影响,
它们来自B细胞表达的CD 21的作用。2)以确定细胞和分子机制
通过该途径,在B细胞中通过C3 aR 1/C5 aR 1的mRNA下调和增强的信号传导驱动亲和力
成熟3)目的:探讨β-CD抑制B细胞增殖的分子基础。这一全面
由具有补体生物学(Heeger)和B细胞生物学专业知识的多PI团队进行分析
(Dominguez-Sola)可能为GC动力学和功能的基本机制提供新的见解。
这些结果有可能指导旨在利用补体/B细胞轴的二级研究,
抑制致病性B细胞应答的发展(例如在移植或自身免疫中)或增强
B细胞应答(例如对疫苗的应答)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Dominguez-Sola其他文献
David Dominguez-Sola的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Dominguez-Sola', 18)}}的其他基金
Decay Accelerating Factor and B cell Immunity
衰变加速因子和 B 细胞免疫
- 批准号:
10406250 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Decay Accelerating Factor and B cell Immunity
衰变加速因子和 B 细胞免疫
- 批准号:
10623288 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Role of FOXO1 mutations in the pathogenesis of B cell non-Hodgkin lymphomas
FOXO1突变在B细胞非霍奇金淋巴瘤发病机制中的作用
- 批准号:
10334435 - 财政年份:2018
- 资助金额:
$ 42.38万 - 项目类别:
Role of FOXO1 mutations in the pathogenesis of B cell non-Hodgkin lymphomas
FOXO1突变在B细胞非霍奇金淋巴瘤发病机制中的作用
- 批准号:
10087895 - 财政年份:2018
- 资助金额:
$ 42.38万 - 项目类别:
ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS
复制应激在 MYC 依赖性淋巴细胞生成过程中的作用
- 批准号:
8146177 - 财政年份:2010
- 资助金额:
$ 42.38万 - 项目类别:
ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS
复制应激在 MYC 依赖性淋巴细胞生成过程中的作用
- 批准号:
7962386 - 财政年份:2010
- 资助金额:
$ 42.38万 - 项目类别:
Role of Replication Stress during Myc-dependent Lymphomagenesis
复制应激在 Myc 依赖性淋巴瘤发生过程中的作用
- 批准号:
8785173 - 财政年份:2010
- 资助金额:
$ 42.38万 - 项目类别:
Role of Replication Stress during Myc-dependent Lymphomagenesis
复制应激在 Myc 依赖性淋巴瘤发生过程中的作用
- 批准号:
8819518 - 财政年份:2010
- 资助金额:
$ 42.38万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Continuing Grant